SCM
AGN

Stonebridge Capital Management’s Allergan Inc AGN Stock Holding History

Stonebridge Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-7,380
Closed -$820K – 201
2013
Q4 		$820K Buy
7,380
+1,755
+31% +$168K 0.33% 63
2013
Q3 		$509K Buy
+5,625
New +$505K 0.23% 90

Other funds holding AGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Stonebridge Capital Management's AGN Position: Q1 2014 in Review

Stonebridge Capital Management sold out of Allergan Inc (AGN) in Q1 2014, closing a stake of 7,380 shares — an estimated $820K sold.

Stonebridge Capital Management first reported a position in AGN in Q3 2013 and held it in 2 quarters. The position peaked at $820K in Q4 2013. 733 funds tracked by Wall St. Rank hold AGN as of Q1 2014.

  • Stonebridge Capital Management reported no remaining Allergan Inc position as of Q1 2014 after selling out during the quarter.
  • Stonebridge Capital Management sold 7,380 Allergan Inc shares in Q1 2014, an estimated $820K.
  • Stonebridge Capital Management first reported a position in Allergan Inc in Q3 2013 and held it in 2 quarters.
  • Stonebridge Capital Management's Allergan Inc position peaked at $820K in Q4 2013.
  • 733 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2014.

Based on Stonebridge Capital Management's 13F filing for Q1 2014, filed 28 Apr 2014.